Criteo S.A.·4

Mar 16, 4:08 PM ET

Damon Ryan 4

4 · Criteo S.A. · Filed Mar 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Criteo (CRTO) CLO Damon Ryan Receives 63,259‑Share Award

What Happened

  • Damon Ryan, Chief Legal Officer of Criteo S.A. (CRTO), received an award of 63,259 ordinary shares (reported as acquisition code A) on March 13, 2026. The Form 4 records an acquisition price of $0.00 (typical for compensation grants); market value is not shown on the form.

Key Details

  • Transaction date: 2026-03-13; Form 4 filed: 2026-03-16 (filed within the SEC’s two-business-day window).
  • Transaction type/code: Award/Grant (A). Price reported on the Form 4: $0.00.
  • Shares owned after transaction: Not specified on this Form 4; filing references the issuer’s proxy statement for more detail (Footnote F3).
  • Footnote highlights:
    • F1: Ordinary Shares may be represented by American Depositary Shares (ADS), 1 ADS = 1 Ordinary Share.
    • F2: Time-based vesting: 25% vests at the 1‑year anniversary, remainder vests in equal quarterly installments over the next 36 months. If the Company’s conversion to a Luxembourg company isn’t completed before the first anniversary, vesting changes to 50% at year 2 with the remainder vesting quarterly over the next 2 years.
  • No indication of a sale, tax withholding, 10b5-1 plan, or late filing on this Form 4.

Context

  • This is a compensation grant (not an open‑market purchase or sale); such awards are routine for executive pay and are subject to the stated vesting schedule. The Form 4 shows the grant but does not assign a market dollar value — investors should consult company filings (e.g., proxy) for total holdings and any additional disclosures.

Insider Transaction Report

Form 4
Period: 2026-03-13
Damon Ryan
Chief Legal Officer
Transactions
  • Award

    Ordinary Shares

    [F1][F2][F3]
    2026-03-13+63,259177,154 total
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.
  • [F2]The shares are subject to time-based vesting as follows: 25% of the shares will vest on the one (1) year anniversary of the grant date, and the remainder of the shares will vest in equal portions at the end of each quarter over the subsequent thirty-six (36) month period. Notwithstanding the foregoing, if the conversion of the Company into a Luxembourg company is not completed before the first anniversary of the grant date, then the shares will be subject to time based vesting as follows: 50% of the shares will vest on the two (2) year anniversary of the grant date and the remainder of the shares will vest in equal portions at the end of each quarter during the two-year period thereafter.
  • [F3]For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
Signature
/s/Ryan Damon|2026-03-16

Documents

1 file
  • 4
    wk-form4_1773691717.xmlPrimary

    FORM 4